Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older
Identifying Attributes
Care Settings
Primary Care
Country
United States of America
Publishing Organisation
Professional Certification or Recognition Program, public reporting, quality improvement
Type of Quality Indicator
Process
IOM Quality Dimension
Effectiveness
Domain
Medications and Medication Management
Defining Attributes
Definition
Percentage of patients aged 50 years and older with a diagnosis of osteoporosis who were prescribed pharmacologic therapy within 12 months
Numerator
Patients who were prescribed pharmacologic therapy within 12 months
Denominator
All patients aged 50 years and older with a diagnosis of osteoporosis
Exclusions
Documentation of medical, patient and/or system reason(s) for not prescribing pharmacologic therapy for osteoporosis
Use of Risk Adjustment
No
Risk Adjustments
None
Stratifications
None
Collection and Reporting Attributes
Type of Data Collection
Administrative data
Data Collection Methods
Claims data
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
No
Source and Reference Attributes
Evidence Source
Technical Specifications
Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
02 December 2025
Contents
Actions
Date Modified 02 December 2025